The Trendlines Group Ltd (42T):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:The Trendlines Group Ltd (42T) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11506
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
The Trendlines Group Ltd (Trendlines) is a commercialization company that invents, discovers, invests, and incubates medical and agricultural technologies. The company offers business incubation, partner and channel development, market strategies, business plans, research and development and commercialization activities, business development, finance and funding strategies, administrative services and other marketing communications services to entrepreneurs. It collaborates and partners with entrepreneurs, investors, strategic players, inventors, governments, agricultural experts and research centers in Israel to improve human conditions and to solve the global food crisis. The company prefers to exit its investments through merger and acquisition transactions. Trendlines is headquartered in Tiberias, Israel.

The Trendlines Group Ltd (42T) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
The Trendlines Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
The Trendlines Group Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
The Trendlines Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
The Trendlines Group Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
The Trendlines Group Ltd, Medical Devices Deals, 2012 to YTD 2018 9
The Trendlines Group Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
The Trendlines Group Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Trendlines Acquires Intellectual Property from Endo 11
Venture Financing 12
ElastiMed Raises USD1 Million in Financing Round 12
Acquisition 13
Arkin Bio Ventures Acquires 3.18% Stake in Biosight from Trendlines Group 13
The Trendlines Group Ltd – Key Competitors 14
The Trendlines Group Ltd – Key Employees 15
The Trendlines Group Ltd – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Strategy And Business Planning 17
Feb 23, 2017: Trendlines Medical Singapore Launches 17
Financial Announcements 18
May 09, 2018: The Trendlines Group Reports 2018 First Quarter Results 18
Feb 22, 2017: The Trendlines Group Reports 2016 Year-End Results 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
The Trendlines Group Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
The Trendlines Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
The Trendlines Group Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
The Trendlines Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
The Trendlines Group Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
The Trendlines Group Ltd, Medical Devices Deals, 2012 to YTD 2018 9
The Trendlines Group Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Trendlines Acquires Intellectual Property from Endo 11
ElastiMed Raises USD1 Million in Financing Round 12
Arkin Bio Ventures Acquires 3.18% Stake in Biosight from Trendlines Group 13
The Trendlines Group Ltd, Key Competitors 14
The Trendlines Group Ltd, Key Employees 15
The Trendlines Group Ltd, Other Locations 16
The Trendlines Group Ltd, Subsidiaries 16

List of Figures
The Trendlines Group Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
The Trendlines Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
The Trendlines Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
The Trendlines Group Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
The Trendlines Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
The Trendlines Group Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
The Trendlines Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
The Trendlines Group Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
The Trendlines Group Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[The Trendlines Group Ltd (42T):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Synopsys, Inc.:企業の戦略・SWOT・財務情報
    Synopsys, Inc. - Strategy, SWOT and Corporate Finance Report Summary Synopsys, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Grupo Televisa, S.A.B. (TLEVISACPO):企業の財務・戦略的SWOT分析
    Grupo Televisa, S.A.B. (TLEVISACPO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Chori Co Ltd (8014):企業の財務・戦略的SWOT分析
    Chori Co Ltd (8014) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Sterling Bank Plc
    Sterling Bank Plc - Strategy, SWOT and Corporate Finance Report Summary Sterling Bank Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Sanwa Holdings Corporation:企業の戦略・SWOT・財務情報
    Sanwa Holdings Corporation - Strategy, SWOT and Corporate Finance Report Summary Sanwa Holdings Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • SATCO Products Inc:企業の戦略的SWOT分析
    SATCO Products Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • OrthoAccel Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary OrthoAccel Technologies Inc (AcceleDent) is a medical device company that manufactures, develops, and markets orthodontic treatment and dental care products. The company’s products include acceledent aura is an accelerated tooth movement device designed for faster orthodontic treatment based …
  • ProAxsis Ltd-医療機器分野:企業M&A・提携分析
    Summary ProAxsis Ltd (ProAxsis), formerly ProAx-Sis Ltd, a subsidiary of NetScientific UK Ltd, is a developer of novel, point of care tests for the monitoring of patients with chronic diseases. The company develops proteasetags based point of care tests to offer a visual readout of active proteases …
  • S&T Dynamics Co., Ltd.:戦略・SWOT・企業財務分析
    S&T Dynamics Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary S&T Dynamics Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • NovImmune SA:製薬・医療:M&Aディール及び事業提携情報
    Summary NovImmune SA (NovImmune) is a biopharmaceutical company that discovers and develops antibody-based drugs for the treatment of inflammatory diseases, immune-related disorders and cancer. The company develops pipeline products using its proprietary mAb generating platform, DiversityTrap and ka …
  • Sutter Health:企業の戦略的SWOT分析
    Sutter Health - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Multi Corporation:企業の戦略・SWOT・財務情報
    Multi Corporation - Strategy, SWOT and Corporate Finance Report Summary Multi Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • J.E. Dunn Construction Group, Inc.:企業の戦略的SWOT分析
    J.E. Dunn Construction Group, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Sanmina Corporation (SANM):企業の財務・戦略的SWOT分析
    Sanmina Corporation (SANM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Mega Corporation Ltd
    Mega Corporation Ltd - Strategy, SWOT and Corporate Finance Report Summary Mega Corporation Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Valeritas Inc:医療機器:M&Aディール及び事業提携情報
    Summary Valeritas Inc (Valeritas) is a medical technology company that develops and commercializes treatment solutions for diabetes. The company’s product includes V-Go insulin delivery device a wearable basal-bolus insulin delivery solution for patients with Type 2 diabetes. It also provides V-Go l …
  • Isagen SA ESP:発電所・企業SWOT分析
    Isagen SA ESP - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (exec …
  • Marks and Spencer Group plc (MKS):企業の財務・戦略的SWOT分析
    Marks and Spencer Group plc (MKS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • NicOx SA (COX):企業の財務・戦略的SWOT分析
    Summary NicOx SA (NicOx) is an ophthalmology company that develops solutions to help maintain vision and improve ocular health. The company’s products include Vyzulta, a latanoprostene bunod ophthalmic solution; and Zerviate, a cetirizine ophthalmic solution. It offers products in the therapeutic ar …
  • Bankers Insurance Group:企業の戦略・SWOT・財務情報
    Bankers Insurance Group - Strategy, SWOT and Corporate Finance Report Summary Bankers Insurance Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆